CBU
BMY icon

CIBC Bank USA’s Bristol-Myers Squibb BMY Stock Holding History

CIBC Bank USA’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1.35M Buy
21,037
+1,437
+7% +$82.3K 0.18% 77
2019
Q3 		$994K Buy
19,600
+1,859
+10% +$87.4K 0.14% 93
2019
Q2 		$805K Buy
17,741
+6,969
+65% +$325K 0.11% 115
2019
Q1 		$514K Buy
10,772
+3,122
+41% +$156K 0.07% 152
2018
Q4 		$398K Buy
7,650
+35
+0.5% +$1.88K 0.06% 159
2018
Q3 		$473K Sell
7,615
-250
-3% -$14.8K 0.06% 161
2018
Q2 		$435K Sell
7,865
-2,500
-24% -$135K 0.06% 168
2018
Q1 		$655K Buy
10,365
+50
+0.5% +$3.22K 0.09% 122
2017
Q4 		$632K Buy
10,315
+250
+2% +$15.6K 0.08% 137
2017
Q3 		$642K Buy
10,065
+1,400
+16% +$81.7K 0.08% 129
2017
Q2 		$483K Sell
8,665
-1,605
-16% -$87.3K 0.06% 156
2017
Q1 		$559K Sell
10,270
-686
-6% -$37.6K 0.08% 134
2016
Q4 		$640K Sell
10,956
-351
-3% -$19.2K 0.09% 126
2016
Q3 		$609K Sell
11,307
-3,010
-21% -$193K 0.09% 136
2016
Q2 		$1.05M Buy
14,317
+2,825
+25% +$200K 0.16% 87
2016
Q1 		$733K Sell
11,492
-69
-0.6% -$4.35K 0.13% 98
2015
Q4 		$795K Sell
11,561
-14
-0.1% -$925 0.14% 101
2015
Q3 		$686K Sell
11,575
-54
-0.5% -$3.43K 0.13% 114
2015
Q2 		$774K Buy
11,629
+785
+7% +$51.7K 0.13% 109
2015
Q1 		$699K Buy
10,844
+515
+5% +$32.2K 0.12% 120
2014
Q4 		$610K Buy
10,329
+200
+2% +$11.3K 0.11% 151
2014
Q3 		$519K Hold
10,129
– – 0.1% 162
2014
Q2 		$491K Sell
10,129
-55
-0.5% -$2.71K 0.09% 177
2014
Q1 		$529K Sell
10,184
-1,905
-16% -$101K 0.11% 167
2013
Q4 		$642K Sell
12,089
-4,290
-26% -$219K 0.14% 152
2013
Q3 		$758K Sell
16,379
-43,226
-73% -$1.9M 0.19% 120
2013
Q2 		$2.66M Buy
+59,605
New +$2.59M 0.16% 106

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CIBC Bank USA's BMY Position: Q4 2019 in Review

CIBC Bank USA increased its Bristol-Myers Squibb (BMY) stake by 7.3% in Q4 2019, buying an estimated $82.3K and bringing the position to 21,037 shares worth $1.35M. The position accounts for 0.18% of the portfolio, ranked #77.

CIBC Bank USA first reported a position in BMY in Q2 2013 and has held it in 27 quarters since. The position peaked at $2.66M in Q2 2013. 2,217 funds tracked by Wall St. Rank hold BMY as of Q4 2019.

  • CIBC Bank USA held 21,037 shares of Bristol-Myers Squibb worth $1.35M as of Q4 2019.
  • CIBC Bank USA bought 1,437 Bristol-Myers Squibb shares in Q4 2019, an estimated $82.3K.
  • Bristol-Myers Squibb made up 0.18% of CIBC Bank USA's portfolio in Q4 2019, its #77 holding.
  • CIBC Bank USA first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 27 quarters since.
  • CIBC Bank USA's Bristol-Myers Squibb position peaked at $2.66M in Q2 2013.
  • 2,217 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2019.

Based on CIBC Bank USA's 13F filing for Q4 2019, filed 29 Jan 2020.